Application of FACE-Q and NOSE in Nasal Reconstruction with Paramedian Frontal Flap after Skin Cancer Resection

• Published in: Plastic and reconstructive surgery. Global open 2021-04, Vol.9 (4), p.e3533-e3533
• Main Authors: Pagotto, Vitor Penteado Figueiredo, Tutihashi, Rafael Mamoru Carneiro, Ribeiro, Renan Diego Americo, Takahashi, Giulia Godoy, Camargo, Cristina Pires, Busnardo, Fábio de Freitas, Gemperli, Rolf
• Format: Article
• Language: English
• Subjects: Original; Reconstructive
• ISSN: 2169-7574; 2169-7574
• DOI: 10.1097/GOX.0000000000003533

Nonmelanoma skin cancer (NMSC) is responsible for high morbidity and mortality, resulting in a high cost to the health system. The nose is the leading region affected by this type of tumor and may need reconstruction by tissue transfer. The paramedian forehead flap (PFF) is one of the main options used, and the factors that influence the result should be studied. The FACE-Q questionnaire allows the assessment of appearance, quality of life, and side effects related to the procedure, whereas the Nasal Obstruction Symptom Evaluation questionnaire enables the nose function evaluation. This study evaluates nasal reconstruction with a PFF after resection of NMSC with the FACE-Q questionnaire and Nasal Obstruction Symptom Evaluation. Spearman Rank correlation coefficient tests between the questionnaire results and patients' characteristics were performed. The questionnaires were completely answered by 49 patients who underwent this reconstruction between 2011 and 2019 in a cancer center. The patients' evaluations demonstrate high satisfaction with appearance, quality of life, side effects, and function. Completing reconstruction under 6 months was associated with a higher quality of life among patients ( = 0.002). Reconstruction of lining or scaffold, moment of flap division, complications, and number of operations did not show an association. This study suggests that the PFF is a reliable option for nasal reconstruction. Identifying the total reconstruction time as an impact factor on patients' quality of life should be considered when planning treatment.